• About
    • Company Overview
    • Management Team
    • Board of Directors
    • Science Advisors
    • Neurology Advisors
    • Ophthalmology Advisors
    • Contacts
  • Science
    • Publications
    • Collaborators
  • Pipeline
    • Infantile Neuroaxonal Dystrophy (INAD)
    • Friedreich’s Ataxia (FA)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Progressive Supranuclear Palsy (PSP)
    • Dry AMD
    • Future Targets
  • Patient Resources
    • Expanded Access Policy
    • Clinical Trials
    • Additional Resources
  • News & Events
    • Press Releases
    • News
    • Events
    • Videos
  • Careers
HomeSciencePublicationsSite-specifically deuterated essential lipids

Site-specifically deuterated essential lipids

Site-specifically deuterated essential lipids as new drugs against neuronal, retinal and vascular degeneration

An original approach to drug discovery and development is now in clinical and preclinical trials. The approach is based on the ‘kinetic isotope effect’ (i.e., the effect of isotopic substitution on chemical reaction rates). By replacing selective hydrogen atoms with deuterium in essential and conditionally essential lipids, a novel class of potent drugs is being created that prevents cellular and vascular oxidative damage causing diverse pathologies, such as neurodegeneration, atherosclerosis and macular degeneration. This review describes the molecular mechanisms underlying the new treatment modalities in these diseases and the encouraging results of ongoing studies for candidate drugs. Also, the possible extension of this new drug platform to treatment of nonoxidative diseases by deuterium- reinforced amino acids and nucleobases is briefly discussed.

Read more…

About
Science
  • Publications
Pipeline
  • Clinical
  • Preclinical
  • Future Targets
Patient Resources
  • Expanded Access Policy
News & Events
Careers
RETROTOPE, 4300 EL CAMINO REAL, SUITE 201, LOS ALTOS, CA 94022
Copyright ©️ 2015-2021 Retrotope Inc.
You are leaving Retrotope’s website. Retrotope does not guarantee the accuracy or completeness of the information contained on any third-party sites, nor does it endorse any of the opinions or information contained on those sites. Please click CONFIRM to continue. CONFIRM